Drugs / simeticone
simeticone
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT03106922 | Apr 2016 → Jul 2020 | — | Alfasigma S.p.A. | Unknown | No outcome recorded |
| Phase 3 | NCT02211976 | Oct → Nov 2003 | constipation disorder | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT01404923 | Dec 2009 → Oct 2011 | irritable bowel syndrome | Laboratoires Mayoly Spindler | Completed | No outcome recorded |
| Phase 4 | NCT00807326 | Nov 2008 → Aug 2009 | diarrheal disease | McNeil AB | Completed | No outcome recorded |
| Phase 4 | NCT00542295 | Jul 2007 → Jul 2008 | irritable bowel syndrome | Laboratoires Mayoly Spindler | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06367452 Background | Oct 2023 → Jan 2024 | — | Tecnoquimicas | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | simeticone | “Sachet A: macrogol 4000 52.500 g, anhydrous sodium sulphate 3.750 g, simeticone 0.080 g;” NCT03106922 ↗ |
| Known as | Asilone windcheaters | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗ |
| Known as | Infacol | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗ |
| Known as | Phazyme | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗ |
| Known as | Simeticona | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗ |
| Known as | Wind-eze | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗ |
| Known as | Windsetlers | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108741 ↗ |
| Route | Oral | “Oral, 2 caplets taken initially at investigator site followed by one caplet after each unformed stool” NCT00807326 ↗ |